proteins mediate virus infection and interference and are critical determinants of disease specificity. In this study, we examined the biochemical and genetic determinants of SU important to virus entry and cell killing. In particular, we developed and used vesicular stomatitis virus (VSV)/FeLV pseudotype virus interference assays to determine interference subgroupings and assess mechanisms of host cell restriction. We also assessed roles of SU in virus growth kinetics and in the inhibition of cell killing caused by superinfection with cytopathic virus. Subgroup classification by VSV/FeLV pseudotype assay was in agreement with that defined previously by focus interference assay and was found to be determined by changes near the N terminus of SU for FeLV subgroups A (FeLV-A) and C. Virus host range restriction was found to be mediated at the level of virus entry in most cases, although postentry events mediated restriction in the failure of a subgroup A-like, T-cell cytopathic and immunodeficiency-inducing clone (FeLV-FAIDS-EECC) to replicate in feline fibroblasts. FeLV-FAIDS-EECC-induced cell killing was also inhibited by prior infection with one of two FeLV-A isolates. This inhibition could be conveyed by as few as four amino acid changes near the N terminus of the FeLV-A SU and also appeared to be mediated at a postentry level. Lastly, the SU-coding sequence was also found to determine differences in growth kinetics of viruses within the same subgroup. These studies demonstrate that subtle alterations in the FeLV SU, particularly in the N-terminal region, impart multiple significant functional differences which distinguish virus variants.
Exogenous feline leukemia viruses (FeLVs) have been classified into three subgroups (A, B, and C) by superinfection interference (52, 53) . FeLVs induce a diverse spectrum of lymphoreticular and hemopoietic diseases in cats, and there is evidence that disease type may correlate with the FeLV subgroup(s) present in the infected animal (17, 30) . Interference subgroup (53) and in vitro host range (23) are considered to be determined by the portion of the envelope gene that encodes the surface glycoprotein (SU). Subgroup A FeLVs (FeLV-A) are ecotropic, horizontally transmitted, present in all natural infections (22, 24) , and can induce long-latency lymphoma. The FeLV-Glasgow-1-A isolate (FGA) (59) is the only molecularly cloned FeLV shown by the criterion of interference to belong to the A subgroup. Subgroup B FeLVs (FeLV-B) exhibit an extended host range in vitro (51, 54) and always occur in association with FeLV-A. Subgroup B viruses are formed by recombination between the FeLV-A env gene and endogenous provirus-like elements, giving rise to the FeLV-B env gene (37, 38, 59 ). FeLV-Gardner-Arnstein-B (FGB) and FeLV-Rickard-B (FRB) are the only molecularly cloned FeLV-B isolates classified by interference (12, 28) . Subgroup C FeLVs (FeLV-C) (22) are also only found in association with FeLV-A and are associated with fatal erythrocyte aplasia (19, 21, 33, 46) . As with FeLV-B, FeLV-C isolates exhibit broadened host range and are unique in their ability to infect guinea pig fibroblasts (51, 54) . FeLV-Sarma-C (FSC) is the molecularly cloned prototype (46) .
An immunodeficiency disease-inducing FeLV isolate (FeLV-FAIDS), originally classified as a mixture of FeLV-A and -B (18, 29) , was found to consist of subgroup A-like "common form" viruses (clone 61E is the prototype) and a family of immunodeficiency disease-associated variants (clone 61C is the prototype). Molecular clone 61C, although replication defective, could propagate in the presence of 61E as helper virus, and with 61E was used to construct a replication-competent chimera, designated EECC. 61E/61C mixtures and the chimera EECC cause T-cell killing in vitro (6) and induce immunodeficiency disease in vivo (6, 35, 41) . T-cell killing by 61E/61C virus mixtures or chimeras is associated with massive superinfection and is preventable postinfection by adding virus neutralizing antiserum to block superinfection (6) .
Although FeLV-A isolates have generally been found to be slowly pathogenic, their presence in all natural infections suggests that FeLV pathogenesis may involve interactions between multiple viruses, a concept first suggested by the work of Jarrett et al. (21) . Although interference among oncoviruses has long been established, the possible interplay between coinfecting virus variants in the development of disease remains to be elucidated. For Table 1 ); numbers at the bottom refer to the seven regions that compose this portion of the viral genome, delineated by restriction endonuclease sites or PCR primer sites (P1 and P2). Each amino acid that differs from that found in 61E is shown with a vertical line; the shaded boxes correspond to Vl, V4, and V5 and indicate clusters of multiple changes (see Fig. 2 for details). Virus chimera growth kinetics are characterized as fast, which corresponds an average of 2 to 3 weeks after infection for a culture to be scored as ELISA positive, or slow, corresponding to an average of 5 to 6 weeks for a parallel culture to be scored as ELISA positive. The effect of prior infection with the virus chimera shown on cell killing caused by subsequent infection with the cytopathic chimera EECC is shown in the far right column. The sequence of the first 163 bp of region 1 from FGA, corresponding to the pol gene segment, had not been reported previously but was sequenced in this study, and no nucleotide or amino acid changes relative to the 61E sequence were found (data not shown).
focus-forming virus interact to induce cytostatic effects on murine bone marrow cells and fibroblasts (27) is not well understood.
We have therefore sought to reexamine the process of superinfection and to examine the biochemical and genetic determinants within FeLV SU that mediate infection and interference.
MATERIALS AND METHODS
Viruses. The FeLV strains used in this study, all derived from molecularly cloned proviruses, were as follows: 61E (5, 35) , FGA (59), FGB (28) , FRB (12) , FSC (46) , 61E/61C chimeras, and the 61E/FSC (6, 34) [VSV(FeLV) ] were generated by using VSV tsO45, an Indiana strain harboring a mutant exterior envelope glycoprotein that is thermolabile and temperature sensitive for synthesis (13) .
Generation of FeLV recombinant viruses. The nomenclature system used to describe FeLV virus chimeras is illustrated in Fig. 1 a The biological strain of origin and each molecularly cloned feline leukemia virus used in this study is listed by its three-letter designation as follows: 61E (5, 35) and 61C (and its replication-competent derivative, EECC) (35) , both derived from the FeLV-FAIDS isolate (18) ; the subgroup A FGA derived from the Glasgow-1 isolate (59); the subgroup C FSC (46) derived from the Sarma isolate (53); and the subgroup B isolates FGB (28) and FRB (12) , derived from the Gardner-Arnstein (14) and Rickard (44) strains, respectively.
b The three letters outside the bracketed region refers to the 61E origin of gqg, pol, and TM-LTR regions, respectively.
C Subgroup determination made in this study.
to the overlap extension method (20) . A series of six primers was generated; primers A (5'-CTTCAAACCAGGAGACTC CGTCTG; the 3' end is base 5789 in the 61E genome [5] ) and B (5'-GGCACTAATTGCTCTTCTA; the 3' end is complementary to base 7464) flanked the SU-coding sequence, whereas primers C and D and primers E and F were complementary pairs which annealed to conserved sequences between the regions of interest (C = 5'-ACATACC TAGCCTTAAATGCCA [ (47, 57) , and hereafter referred to as FeT cells for descriptive purposes, was maintained in 50% L15 (GIBCO)-50% RPMI 1640 (Hazelton or Sigma) supplemented with penicillin, streptomycin, glutamine, and 20% FBS.
Antibodies and Antisera. C11D8 is a murine monoclonal antibody shown to have neutralizing activity directed against all of the strains of FeLV used in this study (16) (52, 53) . We used an alternative technique developed by Zavada (62, 63) , the pseudotype interference assay, in which VSV genomes are packaged within retrovirus envelopes and used to infect retrovirus-infected cells. Sommerfelt and Weiss (58) initially reported production of relatively low levels of VSV(FeLV) pseudotypes. We found that higher levels of VSV(FeLV) pseudotypes were produced by VSV superinfection of FeLV-infected D17 or MLF cells but were not detectable following VSV superinfection of FeLV-infected FeF or FeT cells (data not shown). We also found that the titers of VSV(FeLV), unlike most VSV (retrovirus) pseudotypes (58) , were reduced to below detection levels by freezing (data not shown). We therefore expressed infectivity as the ratio of titer on a test cell line relative to titer on a standard, uninfected cell line examined in each experiment.
D17-derived VSV(FeLV-B) and VSV(FeLV-C) pseudotype stocks had average titers of 2.1 x 104 and 1.5 x 104, respectively; however, D17-derived VSV(FeLV-A) pseudotype titers were over 10-fold lower. In contrast, VS- lope glycoprotein and has postbinding neutralizing activity against representatives of all three FeLV subgroups (15, 16) . The C11D8 stock used neutralized >80% of the VSV(FeLV) pseudotypes derived from each of these three subgroups (Table 2) . That EECC envelope glycoprotein binds to C11D8 (39, 43) and blocks the superinfection-associated cytopathic consequences of infection (6) Table 2 are consistent with, and thus we adopted, the subgrouping convention established by Sarma and Log (52, 53) using a focus induction interference assay. Accordingly, FGA, FGB (and FRB), and FSC were considered prototype FeLV-A, -B, and -C isolates, respectively (2, 28, 46, 59) . As seen in Table 2 (45, 54) , VSV(FeLV-C) pseudotypes infected GP104 cells, whereas VSV(FeLV-A) and VSV(FeLV-B) pseudotypes did not (Table 5) by EECC, the determinants of which were mapped to as an FGA C-terminal determinant was also found in the multiple changes principally found in the N-terminal portion FSC V4 region (Figs. 1 and 2) . Thus, SU-mediated determiof the SU protein ( Fig. 3B and D Fig. 3B and D ; summarized in Fig. 1 ). cells. As cloned directly from tissues, highly pathogenic Cell killing and growth retardation observed in infected FeLV-FAIDS viral genomes (61C is the prototype) have and uninfected target cells was quantitatively assessed by been replication defective and thus have required helper analysis of infections initiated with threefold serial dilutions viruses (61E, cloned from the same cat tissue, is the protoof EECC (Table 7) . When cell killing was assessed, prior type) for transmission (35, 36) . We have therefore explored infection with chimera [GGGGGGG] was found to be equivthe interactions that occur as a result of dual virus infection alent to initiating the infection with 40-fold less EECC, (2) Titer is reported as the ratio of titer on a given target cell versus titer on uninfected FeF cells. The range of values obtained is shown. The number of experiments on which the range is based is given in parentheses. VSV(FeLV-A) pseudotypes were generated in MLF cells; VSV(FeLV-B) and VSV(FeLV-C) pseudotypes were generated in D17 cells. Symbols, abbreviation, and criteria are the same as for (6) . Electroporations were performed a minimum of two times with each plasmid. SU-coding sequences are divided into four sectors here rather than seven since these chimeras were generated in a previous study (6) . See Fig. 2 
DISCUSSION
Previous studies demonstrated the importance of FeLV SU proteins in determining disease type specificity, the kinetics and efficiency of disease induction in vivo, and cell killing in vitro (6, 36, 41, 45) . Our goal in this study was to begin dissection of the distinct virologic properties imparted by SU proteins from biologically distinct FeLVs.
FeLV-FAIDS clone 61E had been tentatively classified as FeLV-A because of the close homology of its envelope gene sequence to that of FGA and its generally ecotropic host range (5 (Fig. 2) . The mutual interference of chimera [ESSEEEE] with FSC more finely localized a FeLV-C subgroup determinant to 5' of the DraIII site (Fig. 2) . VSV pseudotypes bearing envelope genes from three additional FeLV-C isolates (FZ215, FZ246, and FA27 [33] ) have also been used recently to demonstrate that the subgroup C determinants colocalize to region 3 of SU (2) . Domer and Coffin (7) localized receptor-determining regions of the avian leukosis virus (ALV) SU protein to two regions in the middle third of gp85. The murine retrovirus 1OAl, which is inferred to utilize two separate receptors, has been interpreted to have three receptor-determining sites, near positions 12, 30, and 63% along SU (34) . Thus, whereas amino acid changes that specify FeLV-A/FeLV-C receptor choice are localized to a small region of SU, both the avian and murine virus studies demonstrate that combinations of sequences from more than one region can be involved in determining receptor specificity.
In contrast to FeLV-A and FeLV-C, neither of two FeLV-B clones nor VSV(FeLV-B) pseudotypes were found to infect FeT cells. FeT cells may lack some factor, for Fig. 1 , with only regions 2 to 7 shown. Amino acids are replaced with dot when the same as those found in 61E. In a previous study (6) , chimeras generated between 61E and 61C were divided into four sectors and used for the studies reported in Table 6 . These sector borders and identities are shown below each aligned region. Potential N-linked glycosylation sites are underlined.
example, a cell surface receptor, that is necessary for FeLV-B penetration into these cells. Alternatively, the low levels of endogenous FeLV envelope mRNA produced in these cells (27a, 31a, 38) (37, 59) . The monoclonal antibody C11D8 (11, 16) binds to and blocks infection by the two FeLV-B isolates examined here. Its epitope sequence is found within feline endogenous FeLV-related sequences (26, 27a ), yet it fails to bind to the surface of uninfected FeT cells, suggesting that if the endogenous viral protein is produced and the C11D8 epitope is appropriately expressed (32) , the endogenous FeLV protein may interfere by blocking the receptor from reaching the cell surface. This hypothesis would be consistent with the receptor downregulation observed through study of avian reticuloendotheliosis viruses (4).
We found some discordance between host range and interference properties within the subgroup A viruses. Al From the partial interference observed, it remains plausible that FeLV-A and EECC use the same single receptor. According to this hypothesis, the inefficient blockade of EECC infection and cytopathicity by FeLV-A could result from a lower affinity of FeLV-A than EECC for the receptor or from a reduction of the number of receptor molecules on infected cell membranes. Partial interference might then be sufficient to impair superinfection-mediated cytopathicity. However, it is also possible either that EECC employs a receptor in addition to the subgroup A receptor on FeT cells that provides a less efficient (as a result of low abundance or low affinity) portal of entry or that EECC employs both a common and a required secondary receptor, the latter of which would be distinct from that of the subgroup-specific secondary receptor for FeLV-A. We have shown elsewhere (43) that purified 61E and 61C proteins coprecipitate a 70-kDa cell surface protein, despite exhibiting distinct interference properties. Data suggesting that all FeLV subgroups employ a common initial receptor or docking protein but that subgroup specificity is provided by secondary, postbinding interactions at the cell membrane have recently been presented (1, 3) . Lastly, if FeLV SU proteins, like those of other retroviruses, function within multimeric structures (10, 60) , it is also conceivable that the heteromultimeric SU proteins that might form between EECC and FeLV-FGA SU proteins in coinfected cells are more efficient at superinfection blockade than are SU homomultimers.
The observation that EECC can superinfect FeT cells infected with either homologous or subgroup A FeLV suggests that cell killing and disease induction by EECC might be related to the inability of some feline cells to prevent this superinfection. Indeed, 61C SU fails to establish superinfection interference to homologous virus challenge in the absence of virus replication (43) . Analogy can be made to the study of ALV, for which a lack of or delay in the establishment of superinfection resistance leads to cell killing in cells infected with ALV-B and ALV-D (61). ALV-B and ALV-D display mutual interference, fail to establish complete receptor blockade, and induce cytopathicity correlated with an accumulation of unintegrated viral DNA (61) . Use of the ALV-B receptor appears both necessary and sufficient to induce cytopathicity (7) . ALV-B and ALV-D isolates also differ in host range; ALV-D grows in chick cells that lack the ALV-B receptor and are able to penetrate some mammalian cells (9) . ALV-E isolates do not induce acute disease and do not prevent superinfection by ALV-B and ALV-D, even though superinfection by ALV-E is prevented by preinfection with ALV-B or ALV-D. Within the phenotypically heterogeneous A subgroup of FeLVs, then, are properties analogous to those that distinguish three ALV subgroups. Further dissection of FeLV-A isolates awaits isolation and analysis of their interactions with a cellular receptor(s).
